What is the effectiveness of and what are the best practices for using contingency management and incentives for health care issues such as HIV, STIs, and PrEP?
What is the effectiveness of and what are the best practices for using contingency management and incentives to support linkage to care and treatment for hepatitis C infection among people who use drugs?
What are the benefits of universal antiretroviral therapy (ART) coverage on individual and population level health outcomes?
What is the impact of nonadherence to antiretroviral therapy (ART) on population-level health outcomes?
What structural, process, and outcome measures are used to monitor and evaluate the impact of supervised consumption services (SCS)?
